PHARMACEUTICAL RAW MATERIALS AND EXCIPIENTS OPTIONS

“The present scenario has exposed some structural weaknesses during the EU’s medicines provide chain and also a large dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides mentioned. She advised that supply chain concerns be dealt with in an EU pharmaceutical approach envisioned to become introduced